Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shaoma Zhijing granule for tic disorder in children (Phase IV)
ChiCTR2200057938Phase 4Recruiting
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- Feb 2022
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Shaoma Zhijing granule in tic disorder, Tourette syndrome (TS) and chronic tic disorder, sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Yale Global Tic Severity Scale (YGTSS). Started Feb 2022; status: recruiting.
02
Drugs
Shaoma Zhijing granule
03
Conditions
tic disorderTourette syndrome (TS)chronic tic disorder
Beyond the preview
Go deeper on ChiCTR2200057938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057938.